Ericka L Crouse
Associate Professor
Department of Pharmacotherapy & Outcomes Science
Faculty/Staff picture
  •   Smith Building, Room 336
  • School of Pharmacy
    Dept of Pharmacotherapy & Outcomes Science

    410 N 12th Street
    P.O. Box 980533
    Richmond, VA 23298-0533
  •  (804) 628-5071

Area of Focus

  • Mental Health, Substance Use Disorders


  • Pharm.D., (University of Florida, 2003)

Post-Graduate Training

  • Specialty Residency - - in Psychiatry (VCU Health System, 2005)
  • Specialty Residency - in Geriatrics (Durham VAMC, Durham NC, 2004)

Professional and Scholarly Interests

  • Geriatrics, Geriatric Psychiatry, Schizophrenia, Mental Illness, Substance Use Disorders


Recent Publications

  • Crouse E, Haught J, Tobarran, et al. Skin necrosis following inadvertent dermal injection of extended-release buprenorphine. J Addict Med 2021; online ahead of print. Patel SM, Crouse EL, Levenson JL. Evaluation of intramuscular olanzapine and ziprasidone in the medically ill. Ment Health Clin 2021;11(1):6-11. Bozymski KM, Crouse EL, Titus-Lay EN, et al. Esketamine: A novel option for treatment-resistant depression. Ann Pharmacother 2020;54:567-76. Alastanos JN, Potter TG, Crouse EL. Lithium-related medication problems on nonpsychiatric inpatient medical units. Am J Health Syst Pharm 2019;76 (Suppl 4): S96-S101. Bozymski KM, Potter TG, Venkatachalam V, Pandurangi AK, Crouse EL. Caffeine sodium benzoate for electroconvulsive therapy augmentation. J ECT 2018;34(4):233-39. Crouse EL, Alastanos JN, Bozymski KM, Toscano RA. Dysphagia with second-generation antipsychotics: a case report and review of the literature. Ment Health Clin 2018;7(2):56-64.